News

AlphaLife Sciences Announces Veeva RIM Integration to Power AI-Orchestrated Authoring and QC

New Jersey—March 30, 2026—AlphaLife Sciences, a pioneer in GenAI-powered solutions for the life sciences industry, today announced a seamless integration between its flagship AuroraPrime RMA (Regulatory and Medical Authoring) platform and Veeva RIM . This integration marks a significant milestone in the company’s mission to modernize drug development by embedding "Agentic AI" directly into the regulatory value chain.

As the pharmaceutical industry faces increasing pressure to accelerate submission timelines while maintaining rigorous compliance, the disconnect between data repositories and document authoring tools has become a critical bottleneck. By integrating AuroraPrime’s GenAI capabilities with Veeva RIM’s unified regulatory platform, AlphaLife Sciences is enabling data to flow seamlessly from source to submission.

Unlocking "In-the-Flow" AI for Regulatory Excellence

The integration allows medical writers and regulatory professionals to leverage AuroraPrime’s advanced GenAI agents within Microsoft Word while referencing authoritative content from Veeva RIM in real time.

"The future of regulatory excellence belongs to organizations that can bridge the gap between their data and their documents," said Sharon Chen, CEO of AlphaLife Sciences. "By integrating AuroraPrime with Veeva RIM, we are accelerating document authoring. Our partnership enables AI agents to access documents and data in Veeva Vault to draft accurate and high-quality Clinical Study Reports, Protocols, and Safety Narratives in minutes rather than weeks, all while maintaining full traceability."

Key Capabilities of the Integration

As a Veeva AI Partner, AlphaLife Sciences has engineered this integration to deliver enterprise-grade interoperability:

• Unified Authoring Workflow: Users can access and reference upstream documents (such as Protocols and SAPs) stored in Veeva Vault directly within the AuroraPrime Word Add-in. This eliminates the risk of version control errors caused by downloading and storing files locally.

• AI-Orchestrated Drafting: AuroraPrime’s GenAI agents can synthesize structured and unstructured data from Veeva Vault to auto-generate initial drafts of complex documents like CSRs and Module 2 summaries, reducing drafting time by up to 50%.

• End-to-End Traceability: The integration preserves the lineage of information. When AI generates content based on data in Veeva Vault, AuroraPrime RMA maintains a clear audit trail, ensuring that every claim is traceable back to its source—a critical requirement for regulatory compliance.

• Seamless RIM Augmentation: Finalized documents and metadata are synchronized back to the Vault, ensuring that Veeva RIM remains the authoritative record for all regulatory activities.

Validated by Industry Leaders

The urgency for this type of integration was highlighted in a recent Frost & Sullivan white paper, "How Leading Global Pharma Embraces AI to Automate Regulatory and Medical Documents with Quality Control". The report notes that leading pharma companies are prioritizing "in-the-flow" solutions that integrate with existing RIM systems to escape "pilot purgatory" and achieve scalable efficiency.

AlphaLife Sciences’ approach aligns with this industry shift, offering a "production-grade" solution that respects the rigorous security and compliance standards of the biopharma sector, including ISO 27001 and SOC 2 Type II certifications.

About AlphaLife Sciences

AlphaLife Sciences is a global leader in AI-powered clinical and regulatory solutions. Its flagship platform, AuroraPrime, leverages Agentic AI to automate the creation and quality control of complex life sciences documentation. Backed by industry leaders including Microsoft, Google, and NVIDIA, AlphaLife Sciences serves over half of the world’s top 20 pharmaceutical companies, helping them accelerate the delivery of life-saving therapies to patients.

For more information, visit www.alphalifesci.com.